Table of Contents
<< Previous Issue | Feb 2004 (Vol: 2004, Issue: 44) | Next Issue >> |
- Section: Company Profile
-
Intercell AG
- Section: Distribution & Marketing
-
Shire’s Exit Strategy from Japan Provides Bayer with Exclusive Product Rights
- Section: Licensing
-
AstraZeneca and Array BioPharma Sign Oncology Agreement
-
Amgen Licenses Stem Cell Growth Factors to ViaCell
- Section: Mergers & Acquisitions
-
Abbott to Acquire Diagnostics Manufacturer for US$392 M
-
CSL Combines with Aventis to Create ZLB Behring
- Section: Research & Development
-
GlaxoSmithKline and NeuroSearch to Investigate CNS Diseases